Concepedia

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

Eva Havrdová, Steven Galetta, Michael Hutchinson, Dusan Stefoski, David O. Bates, Chris H. Polman, Paul O’Connor, Gavin Giovannoni, J. Theodore Phillips, Fred Lublin,

The Lancet Neurology · 2009 · 473 citations · 13 references

DOI

Concepts

References

13

Rating neurologic impairment in multiple sclerosis

John F. Kurtzke · Neurology · 1983 · 14.9K citations

, , +14

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

W. I. McDonald, Alistair Compston, Gilles Edan et al. · Annals of Neurology · 2001 · 7K citations

, , +10

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

Chris H. Polman, Paul O’Connor, Eva Havrdová et al. · New England Journal of Medicine · 2006 · 3.3K citations · Full text

, , +14

Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

Diane L. Cookfair, Richard A. Rudick, Robert M. Herndon et al. · Annals of Neurology · 1996 · 2.4K citations

, , +12

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

Neurology · 1993 · 2.1K citations

, , +14